Patent details
EP2660238 Title: Compounds for the prevention and treatment of cardiovascular disease
Basic Information
- Publication number:
- EP2660238
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP131755613
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- Compounds for the prevention and treatment of cardiovascular disease
- French Title of Invention:
- Composés pour la prévention et le traitement d'une maladie cardiovasculaire
- German Title of Invention:
- Verbindungen zur Vorbeugung und Behandlung von kardiovaskulären Erkrankungen
- SPC Number:
Dates
- Filing date:
- 08/01/2010
- Grant date:
- 06/05/2015
- EP Publication Date:
- 06/05/2015
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 06/11/2013
- EP B1 Publication Date:
- 06/05/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 08/01/2016
- Expiration date:
- 08/01/2030
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 28/10/2015
- Name:
- Resverlogix Corp.
- Address:
- 300, 4820 Richard Road SW, Calgary, AB T3E 6L1, Canada (CA)
Inventor
- Name:
- Hansen C., Henrik
- Address:
- Canada (CA)
Priority
- Priority Number:
- 143276 P
- Priority Date:
- 08/01/2009
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
- C07D 239/91;
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|